Hiraki, Yoko
Kimura, Yutaka https://orcid.org/0000-0002-0188-0586
Imano, Motohiro
Kato, Hiroaki
Iwama, Mitsuru
Shiraishi, Osamu
Yasuda, Atsushi
Shinkai, Masayuki
Makino, Tomoki
Motoori, Masaaki
Yamasaki, Makoto
Miyata, Hiroshi
Satou, Takao
Satoh, Taroh
Furukawa, Hiroshi
Yano, Masahiko
Doki, Yuichiro
Yasuda, Takushi
Article History
Received: 22 April 2020
Accepted: 15 June 2020
First Online: 28 June 2020
Compliance with ethical standards
:
: Taroh Satoh serves as a consultant to Daiichi Sankyo, Eli Lilly, Chugai Pharmaceutical Co. Ltd., Merck Serono Co. Ltd., Bristol-Myers K.K., Taiho Pharmaceutical Co. Ltd., ONO Pharmaceutical. Co. Ltd. and Takeda Pharmaceutical Co. Ltd.; Taroh Satoh received a research grant from Chugai Pharmaceutical Co. Ltd., ONO Pharmaceutical. Co. Ltd. and Yakult Honsha Co. Ltd.; Taroh Satoh received lecture fees from Eli Lilly, Chugai Pharmaceutical Co. Ltd., Merck Serono Co. Ltd., Bristol-Myers K.K., Taiho Pharmaceutical Co. Ltd., ONO Pharmaceutical. Co. Ltd. and Takeda Pharmaceutical Co. Ltd.. Yoko Hiraki and other co-authors other than Taroh Satoh have no conflicts of interest.
: Approval of the protocol: each institution’s review board approved this research.